Pulmonary Aspergillosis clinical trials

The registry lists 20 studies for Pulmonary Aspergillosis across more than 10 countries. 5 are recruiting or about to start. 11 of them are mainly about Pulmonary Aspergillosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-22. Counting its 2 narrower conditions too, such as Invasive Pulmonary Aspergillosis: 96 studies, 24 open.

Get an email when these change. Save the Pulmonary Aspergillosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 11
Recruiting: 4
Terminated: 1
No longer available: 1
Not yet recruiting: 1
Active, not recruiting: 1

Phase

Phase 2: 5
Phase 1: 3
Phase 3: 2

Where

France: 5
Netherlands: 4
Belgium: 3
Germany: 2
Spain: 2
Italy: 2

Who runs them

Radboud University Medical Center (3) · TFF Pharmaceuticals, Inc. (3) · Fundació Sant Joan de Déu (1) · Nantes University Hospital (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Azienda Ospedaliero-Universitaria Careggi (1) · University Hospital, Basel, Switzerland (1) · Imperial College London (1)

What is being tested here

Drugs under test in Pulmonary Aspergillosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Aviptadil	0	0	2
Opelconazole	0	0	1
Amphotericin B	0	0	1
Fosmanogepix	0	0	1

Coming up

2phase 3 studies under way

4studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

May 2027A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis · Phase 3 · Post Graduate Institute of Medical Education and Research, Chandigarh
Jun 2027Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole · Phase 3 · Poitiers University Hospital
Nov 2026Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options · Mundipharma Research Limited
May 2027Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Radboud University Medical Center

Who these studies take

Of the 4 Pulmonary Aspergillosis studies recruiting now, 3 (75%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 4
Age	Women	Men
10	0 (0%)	0 (0%)
18	4 (100%)	4 (100%)
30	4 (100%)	4 (100%)
40	4 (100%)	4 (100%)
50	4 (100%)	4 (100%)
65	4 (100%)	4 (100%)
75	4 (100%)	4 (100%)
85	4 (100%)	4 (100%)

Across all 20 studies, recruiting or not: 20% stop at 75 or younger and 15% at 65; 15% take children; 0% are for women only and 0% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 20 of 20. search them.